跳至主要内容
临床试验/NCT03626233
NCT03626233招募中不适用

Study of the Physiology of Pre-eclampsia and Vascular Intrauterine Growth Restriction With Constitution of a Biological Collection

Centre Hospitalier Intercommunal Creteil2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2018年8月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
2
主要终点
genomic analysis on placenta

研究概览

简要总结

Preeclampsia and intrauterine growth retardation (IUGR) are serious and frequent pathologies, specific to pregnancy. They represent 70 000 new cases a year, or 9% of pregnancies and cause 50,000 premature births per year in France. The consequences in terms of morbidity and perinatal morbidity and the medical and economic costs make it an issue public health. Pre-eclampsia associates maternal hypertension with dysfunction kidney. There is no cure for pre-eclampsia or IUGR vascular during pregnancy. These pathologies invariably evolve towards a maternal and / or fetal aggravation sometimes very fast. Primary prevention and secondary education and screening for these pathologies are still insufficient. A better understanding of the pathophysiology of these placental vascular pathologies is necessary for the development of supported medical, obstetric and pediatric that will improve the state of health maternal and neonatal

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women
  • With or without vascular pathology

排除标准

  • refusal to participate
  • multiple pregnancy
  • major fetal malformation diagnosed during pregnancy follow-up

结局指标

主要结局

genomic analysis on placenta

时间窗: day of delivery

by chromatin immunoprecipitation-sequencing (ChIP-seq)

次要结局

  • genomic analysis on placenta(day of delivery)
  • PLGF blood level(day of delivery)
  • sFlt1 blood level(day of delivery)
  • genomic analysis on blood(day of delivery)
  • VEGF blood level(day of delivery)
  • sKDR blood level(day of delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验